Analytical Data
-
Gene name
SCPEP1
- Application
-
Alternative Names
HSCP1; RISC; Retinoid Inducible Serine Carboxypeptidase
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q920A6
-
Expression Region
Lys182~Glu452
-
Molecular Weight
34kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCPEP1, or Serine Carboxypeptidase-like Protein 1, has garnered significant attention in recent years due to its potential implications in various biological processes and disease mechanisms. Initially identified for its role in the hydrolysis of peptide bonds, SCPEP1 is involved in the regulation of peptide hormones and neuropeptides, which are critical for numerous physiological functions, including metabolism, growth, and neuroregulation. Research has indicated that SCPEP1 may also play a role in inflammation and cancer progression, making it a target of interest for therapeutic interventions. The recombinant expression of SCPEP1 protein has facilitated in-depth structural and functional studies, allowing scientists to elucidate its enzymatic properties and interactions with various substrates. Furthermore, understanding its regulatory mechanisms can provide insights into its potential as a biomarker or therapeutic target in diseases where dysregulation occurs. As our knowledge of SCPEP1 expands, it paves the way for developing innovative strategies aimed at modulating its activity for therapeutic benefit. Overall, the ongoing research into SCPEP1 highlights its significance in both basic and applied biomedical sciences, offering promising avenues for future investigation and therapeutic developments.
